Related Experiment Videos

Learning and memory impairment in albino rats after potassium ethylxanthogenate. Effects of nootropic agents

M Genkova-Papasova1, M Lazarova-Bakarova

  • 1Institute of Physiology, Bulgarian Academy of Sciences.

Acta Physiologica Et Pharmacologica Bulgarica
|January 1, 1991
PubMed

Insights

Nootropic drugs like piracetam effectively prevented memory impairment in rats caused by potassium ethylxanthogenate, an inhibitor of dopamine-beta-hydroxylase. These findings highlight the protective role of nootropics in cognitive function.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cognitive Science

Background:

  • Dopamine-beta-hydroxylase inhibition can impair cognitive functions.
  • Nootropic agents are explored for their potential to enhance or protect cognitive processes.

Purpose of the Study:

  • To investigate the effects of specific nootropic agents on cognitive deficits induced by potassium ethylxanthogenate.
  • To evaluate the protective potential of piracetam, aniracetam, meclofenoxate, and fipexide against memory impairment.

Main Methods:

  • Experiments were conducted on albino rats.
  • Cognitive functions were assessed using active conditioned avoidance (shuttle-box) and passive avoidance (step-down) methods.
  • Potassium ethylxanthogenate was administered to induce cognitive impairment, followed by administration of nootropic agents.

Main Results:

  • Potassium ethylxanthogenate (100 mg/kg) significantly impaired learning and memory in rats.
  • Oral administration of piracetam (600 mg/kg), aniracetam (50 mg/kg), meclofenoxate (100 mg/kg), and fipexide (10 mg/kg) completely prevented these impairments.
  • The nootropic drugs demonstrated a protective effect against chemically induced cognitive deficits.

Conclusions:

  • Nootropic agents piracetam, aniracetam, meclofenoxate, and fipexide can effectively counteract cognitive impairments induced by dopamine-beta-hydroxylase inhibition.
  • The study suggests the involvement of the noradrenergic system and other neurotransmitter systems in memory disturbances and the protective effects of these nootropics.

Related Concept Videos